PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Fast Ireland delivery — dispatched to Dublin, Cork, Galway, Limerick and nationwide.
PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Fast Ireland delivery — dispatched to Dublin, Cork, Galway, Limerick and nationwide.
By the Peptides Lab Ireland research team · Updated October 2026
The Health Products Regulatory Authority (HPRA) is Ireland’s regulator for medicines, medical devices and other health products. This guide explains, in plain English, what the HPRA does, which products it oversees, and how its role relates to research chemicals and peptides supplied for laboratory research use only. For official information, always go to the HPRA website.
The HPRA is the state agency that regulates medicines, medical devices and health products “for the benefit of people and animals”. It was previously known as the Irish Medicines Board (IMB) and took the HPRA name in 2014 as its remit widened. It is based in Dublin and works within both Irish and EU law, cooperating closely with the European Medicines Agency and other EU regulators. More detail is on the HPRA “About us” page.
In simple terms the HPRA authorises products before they reach the market, inspects manufacturers and distributors, monitors safety once products are in use, and enforces the law, which includes detaining illegal or falsified medicines and acting against unlicensed supply.
Whether a product is a “medicine” depends on two things: how it is presented (for example, claims that it treats or prevents disease in people) and what it is intended to do in the body. A peptide supplied to laboratories strictly for in-vitro research, with no health claims and clear “not for human use” labelling, is generally not presented as a medicine.
That does not put research chemicals beyond the HPRA’s reach. Where a seller markets a compound with treatment claims, human-use instructions or before-and-after imagery, it can be treated as an unlicensed medicine. The HPRA also offers a product classification service to decide how borderline products should be regulated, and its decision is what counts.
GLP-1 type compounds such as semaglutide and tirzepatide are a particular focus of HPRA public warnings about illegal online supply. That is why responsible research suppliers keep their wording strictly to laboratory research.
Keep a purchase order, project reference or protocol that shows what the material is for. This is normal lab practice.
Every vial should state “For laboratory research use only, not for human or veterinary use”. Missing labelling is a red flag.
A CoA tied to the batch number gives you a clear record of what you received. Our CoA guide explains how to read one.
Choose suppliers with a real business identity, named testing labs and accurate customs paperwork.
Questions? Email research@peptideslabireland.com.
The HPRA is Ireland’s national regulator for medicines, medical devices and other health products, for both people and animals. It was formerly called the Irish Medicines Board.
The HPRA regulates products that are medicines. Whether a substance counts as a medicine depends on how it is presented and what it does. Peptides sold only for laboratory research, with no health claims, are generally not presented as medicines, but the HPRA can decide how any product is classified.
Yes. The HPRA runs a product classification service and can decide that a borderline product is a medicine, a medical device, a cosmetic or something else.
No. It is a plain-English overview. For a specific compliance question, contact the HPRA directly or speak to a qualified regulatory or legal adviser.
This article is general information, not legal advice. For specific compliance questions contact the HPRA or a qualified regulatory or legal adviser. All compounds supplied by Peptides Lab Ireland are for laboratory research use only.
Receive News
